Arizona Sued Pharmacy Benefit Managers Over Opioid Crisis
The state alleges that Express Scripts and Optum fueled opioid addiction to boost corporate profits.
Updated on Oct. 1, 2026 in Substance Abuse
Live Poll
Do you trust that pharmacy benefit managers prioritize patient health over their own corporate profits?
Arizona Attorney General has filed a consumer fraud lawsuit against pharmacy benefit managers Express Scripts and Optum. The suit claims the companies knowingly prioritized profit over patient safety during the opioid crisis.
Why it matters
The legal action highlights the role of middlemen in healthcare who are accused of incentivizing opioid distribution. By prioritizing profit over oversight, these firms allegedly bypassed critical safety measures that might have prevented addiction.
The lawsuit targets the business practices of Express Scripts and Optum, specifically alleging that they bypassed prior authorization and step therapy safeguards for opioid medications.
The players
Express Scripts
This is a major pharmacy benefit manager that handles prescription drug coverage for health plans.
Optum
This health services company functions as a pharmacy benefit manager and provides various healthcare operations.
Purdue Pharma
This is a pharmaceutical company notably linked to the manufacturing and marketing of opioid products.
The details
According to the filing, the companies struck secret rebate deals with manufacturers like Purdue Pharma to ensure preferred status for OxyContin and other opioids. Prosecutors allege these firms also sold private patient data to drug makers and sent materials that downplayed the risks of addiction to patients.
Timeline
September 24, 2026: The Arizona Attorney General announced the filing of the consumer fraud lawsuit.
The Big Picture
This litigation follows the pattern established by the national multi-state opioid litigation settlements, targeting the broader ecosystem of entities responsible for the crisis.
Residents may see long-term changes to how their prescription benefits are managed if the state succeeds in forcing new oversight of these companies. This case highlights how administrative choices in pharmacy benefit management can directly influence the availability and safety of powerful drugs.
The takeaway
This case underscores the significant impact that pharmacy benefit managers have on patient safety and the pharmaceutical market. Patients should remain vigilant about their prescribed medications and consult with their providers if they have concerns regarding the risks associated with long-term opioid use.
Further reading
For additional context on the state's efforts to combat addiction, visit the Substance Abuse section.
Live Poll
Do you trust that pharmacy benefit managers prioritize patient health over their own corporate profits?
